-
CHMP highlights: May 2023
CHMP highlights: May 2023
-
CHMP highlights: May 2023
CHMP highlights: May 2023
EMA's human medicines committee (CHMP) recommended 2 new medicines for approval in the EU at its May 2023 meeting
-
Industry guidance to prevent medicine shortages
Industry guidance to prevent medicine shortages
-
Industry guidance to prevent medicine shortages
Industry guidance to prevent medicine shortages
EMA has published recommendations for marketing authorisation holders, wholesalers, distributors and manufacturers to prevent human medicine shortages and reduce their impact.
-
2022 annual report published
2022 annual report published
-
2022 annual report published
2022 annual report published
EMA has published its 2022 annual report that provides an overview of the Agency’s major achievements, key figures and contributions to public and animal health in Europe
-
End of COVID-19 public health emergency
End of COVID-19 public health emergency
-
End of COVID-19 public health emergency
End of COVID-19 public health emergency
EMA's Executive Director, Emer Cooke, issues a statement after the end of the Public Health Emergency of International Concern (PHEIC) for COVID-19 was declared by the WHO.
Information for you
Key content
Services & databases
-
List item
Clinical Trials website
-
List item
Account Management portal
-
List item
eSubmission
-
List item
EudraVigilance (human)
-
List item
EudraVigilance Veterinary
-
List item
Veterinary Medicines information website
-
List item
Suspected adverse drug reactions database
-
List item
Clinical data
-
List item
SPOR data management services
-
List item
Service Desk
-
List item
IRIS platform
-
List item
Public register of parallel distribution notices
-
List item
European Vaccination Information Portal